- Home
- MGPI vs LYEL Comparison
MGPI vs LYEL Comparison
Compare MGPI & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGPI | LYEL |
|---|---|---|
| Founded | 1941 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.4M | 504.8M |
| IPO Year | 1988 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MGPI | LYEL |
|---|---|---|
| Price | $24.88 | $24.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $33.25 | $25.00 |
| AVG Volume (30 Days) | ★ 390.0K | 141.9K |
| Earning Date | 02-25-2026 | 03-10-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $578,855,000.00 | $41,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.67 | $7.65 |
| 52 Week High | $38.11 | $45.00 |
Technical Indicators
Market Signals| Indicator | MGPI | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 41.09 |
| Support Level | $23.05 | $22.67 |
| Resistance Level | $25.18 | $24.96 |
| Average True Range (ATR) | 0.74 | 2.10 |
| MACD | 0.01 | -0.73 |
| Stochastic Oscillator | 77.80 | 18.80 |
Price Performance
Historical ComparisonAbout MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.